Real-time syndromic surveillance and modeling to inform decision-making for COVID-19

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2017
    2022
  • Known Financial Commitments (USD)

    $30,885
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    SHWETA BANSAL
  • Research Location

    United States of America
  • Lead Research Institution

    GEORGETOWN UNIVERSITY
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Real-time syndromic surveillance and modeling to inform decision-making forCOVID-19 Investigators:Shweta Bansal, Associate Professor, Department of Biology, Georgetown UniversityPej Rohani, Professor, Odum School of Ecology & Dept of Infectious Diseases, University of Georgia Project Summary:The rapid spread of COVID-19 around the United States has created an unprecedentedpublic health emergency. It is now clearly appreciated that smart policy responses to thispandemic require the utilization of reliable, validated transmission models. Models are critical both in terms of forecasting the spatio-temporal spread of the virus, but also inpermitting a rational comparison of alternative non-pharmaceutical intervention strategies.To fill this urgent surveillance gap and inform policy decisions, we propose to model thespatio-temporal dynamics of COVID-19 in the US from novel streams of real-timehealthcare data. Our combination of sophisticated computational and statistical models,together with unique high-resolution data will allow a careful characterization of the burdenof COVID-19 beyond tested cases, discriminate among alternative mitigation policies, and quantify the geographic variation in population immunity as we prepare for the Fall wave.1